Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase.
about
RNA interference in the treatment of renal stone disease: Current status and future potentials.An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria.
P2860
Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Metabolism of (13)C5-hydroxypr ...... hydroxyproline dehydrogenase.
@en
type
label
Metabolism of (13)C5-hydroxypr ...... hydroxyproline dehydrogenase.
@en
prefLabel
Metabolism of (13)C5-hydroxypr ...... hydroxyproline dehydrogenase.
@en
P2093
P2860
P1476
Metabolism of (13)C5-hydroxypr ...... hydroxyproline dehydrogenase.
@en
P2093
Abigail Liebow
Brianna Buchalski
Edward W Inscho
John Knight
Kevin Fitzgerald
W Todd Lowther
William Querbes
Xingsheng Li
Zhengrong Guan
P2860
P304
P356
10.1016/J.BBADIS.2015.12.001
P577
2015-12-02T00:00:00Z